Search

everythinglearnresearchcommunity

for

Search:↓

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

AMT may cause hair loss and changing dWAT activity could help treat it.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Genetic analysis of Cashmere goats identified key genes for wool, reproduction, and high-altitude adaptation.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The humanized AA mouse model is better for testing new alopecia areata treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

DM and AA may share a common cause.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Dystonia may be part of PAS-4 and linked to immune issues.

Blocking LFA-1 prevents hair loss in mice.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Belatacept may be a promising treatment for alopecia areata.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Porcine acellular dermal matrix treatment helps wounds heal faster and reduces scarring by affecting Jag1 in skin stem cells.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Digital health technology improves health and medication adherence in kidney transplant patients.

Lambertianic acid helps prevent muscle wasting.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Certain skin proteins can form anchoring structures without the protein AMACO.